Dr Doris M. W Kinuthia

Similar documents
The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

Pediatric Hypertension. Alisa A. Acosta, MD, MPH Asst. Professor, Renal Section April 5, 2019

Approach to patient with hypertension. Dr. Amitesh Aggarwal

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Jared Moore, MD, FACP

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Blood Pressure Measurement (children> 3 yrs)

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

Chronic Pediatric Hypertension

Hypertension Update Background

Diabetes and Hypertension

5.2 Key priorities for implementation

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

Inclusion Criteria: 3 years of age and have had at least 2 visits in the last year Exclusion Criteria: BMI 85 th percentile

Hypertension Update. Aaron J. Friedberg, MD

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Management of Hypertension

Using the New Hypertension Guidelines

DEPARTMENT OF GENERAL MEDICINE WELCOMES

What s In the New Hypertension Guidelines?

2017 AAP Guidelines for Childhood Hypertension

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

hypertension Head of prevention and control of CVD disease office Ministry of heath

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Hypertension in Paediatric Haematology/Oncology

Creative blood pressure management: whys and the tricks

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

Children with Hypertension in ED

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Categories of HTN. Overview of Hypertension. Types of Hypertension

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Presentation of hypertensive emergency

HTN talk_l Davis_ /28/2018

Cardiac Pathophysiology

Treating Hypertension from

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

Egyptian Hypertension Guidelines

How Low Do We Go? Update on Hypertension

Pharmacologic Management of Hypertension

Summary of recommendations

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Blood Pressure Treatment in 2018

Hypertension Clinical case scenarios for primary care

Genetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension.

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Hypertension and Cardiovascular Disease

Reference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Hypertension in the very old. Objectives: Clinical Perspective

Take The Stress Out of Pediatric Hypertension! Rasheda Amin, MD Division of Nephrology Pediatric Specialists of Virginia George Washington University

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept


major public health burden

M2 TEACHING UNDERSTANDING PHARMACOLOGY

Update on Current Trends in Hypertension Management

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 March 2011

Combination Therapy for Hypertension

Objectives. Describe results and implications of recent landmark hypertension trials

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

PEDIATRIC HYPERTENSION CLINICAL PRACTICE GUIDELINES. Milena Archuleta, MSN, MBA, FNP-BC, CPHON University of New Mexico Hospital

Hypertension. Most important public health problem in developed countries

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure

HYPERTENSION: ARE WE GOING TOO LOW?

Management of High Blood Pressure in Adults

Children s Mercy Hospitals and Clinics Evidence Based Practice Care Process Model

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MPharmProgramme. Hypertension (HTN)

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

CLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension.

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Update in Hypertension

Special Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz

The Failing Heart in Primary Care

Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Summary/Key Points Introduction

Incidental Findings; Management of patients presenting with high BP. Phil Swales

Hypertension (JNC-8)

Treating Hypertension in 2018: What Makes the Most Sense Today?

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES

A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE OBJECTIVES

Hypertension Guidelines 2017

DIRECT RENIN INHIBITOR (DRI) EFFECT ON GFR AND USE IN RENAL ARTERY STENOSIS SCREENING

Transcription:

Dr Doris M. W Kinuthia

Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of hypertension in children Conclusion

INTRODUCTION o Hypertension can begin in childhood or adolescence o It can contribute to the early development of cardiovascular disease (CVD). o Identifying children with HTN and successfully treating their HTN has impacts on long-term outcomes of CVD.

Pathophysiology of Hypertension Blood pressure is determined by the balance between cardiac output and vascular resistance A rise in either of these variables, in the absence of a compensatory decrease in the other, increases mean BP

Epidemiology Of Hypertension In Children In the USA Since the late 1980s, the prevalence of HPB has increased in children o The prevalence of children with BP value >95th percentile has increased from 2.7 to 3.7 % o The prevalence of pre-hypertension increased from 7.7 to 10% o The mean SBP increased by 1.3 mmhg and the mean DBP increased by 8.4. o The rise in BP is correlated to an increase in the prevalence of obesity Sorof.JM.et al Paediatrics 2004;113 (3rd 1)475-483

Measuring Blood Pressure in Children The 4 th report of the National High Blood Pressure Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents (2004)reexamined blood pressure data and revised blood pressure tables for children

Blood Pressure in Children and Adolescents o Normal range of blood pressure determined by body size and age o Blood pressure standards developed based on age, gender and height of healthy population o Blood pressure measurement preferred in the right upper extremity o Routine measurement from 3 years (Fourth report on childhood BP, NHLBI)

Blood pressure measurement

Ambulatory Blood Pressure Monitoring Is useful in the evaluation of: White-coat hypertension Target-organ injury risk Apparent drug resistance Drug-induced hypotension. Provides additional BP information in: Chronic kidney disease Diabetes Autonomic dysfunction..

Blood Pressure Tables BP standards based on sex, age, and height provide a precise classification of BP according to body size. The revised BP tables now include the 50th, 90th, 95th, and 99th percentiles by sex, age, and height.

Height Percentiles in Children and Adolescents Age, y 95th BP Percentile for Girls, mm Hg 95th BP Percentile for Girls, mm Hg 95th BP Percentile for Boys, mm Hg 95 th BP percentile Boys 50th Height Percentile 50th Height Percentile 75th Height Percentile 50th Height Percentile 75th Height Percentile 1 104/58 104/58 105/59 103/56 6 115/75 111/74 113/74 114/74 12 125/82 123/80 124/81 123/81 17 138/87 129/84 130/85 136/87

Measurement of Blood Pressure in Children Children >3 years old should have their BP measured. Correct measurement requires a cuff that is appropriate to the size of the child s upper arm. Elevated BP must be confirmed on repeated measurement. BP >90th percentile obtained by oscillometric devices should be repeated by auscultation.

Classification of Hypertension in Children and Adolescents with Measurement Frequency Frequency of Measurement Normal Recheck at next scheduled physical examination. Prehypertension Stage 1 hypertension Recheck in 6 months. Recheck in 1 2 weeks or sooner if the patient is symptomatic; if BP is persistently elevated on two additional occasions, evaluate or refer to source of care within 1 month. Stage 2 hypertension Evaluate or refer to source of care within 1 week or immediately if the patient is symptomatic.

Classification of Hypertension in Children Essential /Primary o No underlying cause identified. o common in older children postpubertal o Family history of HTN o Patients are overweight and obese. o Mild hypertension (BP at or just above the 95 th percentile o Most common in African Americans Secondary /Systemic o An identified cause is established. o BP > 95 th percentile o Seen in younger childrenprepubertal o No family history of HTN o Poor response to treatment

Aetiology of Hypertension in children with relation to the age

Secondary HTN in Children More common in children than adults Consider this possibility in every child with HTN Majority of children with secondary hypertension will have renal or renovascular disease Thorough history and physical exam will likely give clues to underlying problems

The goals of the initial evaluation of the hypertensive child or adolescent o Distinguish between primary versus secondary hypertension o Identify the cause of the secondary hypertension o Identify co-morbid risk factors or diseases associated with an increased risk for cardiovascular disease e.g.( obesity,dyslipidemia or diabetes mellitus) o Identify children who can be treated with antihypertensive drug therapy.

Primary Hypertension and Evaluation for Comorbidities Primary hypertension can occur in children and adolescents Hypertension and prehypertension are significant health issues in the young This is due to the marked increase in the prevalence of overweight children. Evaluation of hypertensive children should include assessment for additional risk factors

Clinical Evaluation of Confirmed Hypertension Study or Procedure Purpose Target Population Study or Procedure Purpose Evaluation for identifiable causes History, History and physical including sleep history, examination help focus family history, risk subsequent evaluation factors, diet, and habits such as smoking and drinking alcohol; physical examination All children with persistent BP 95th percentile History, History and physical including sleep history, examination help focus family history, risk subsequent evaluation factors, diet, and habits such as smoking and drinking alcohol; physical examination BUN, creatinine, electrolytes, urinalysis, and urine culture R/O renal disease and chronic pyelonephritis All children with persistent BP 95th percentile CBC R/O anemia, consistent All children with with chronic renal disease persistent BP 95th percentile CBC R/O anemia, consistent with chronic renal disease Renal U/S R/O renal scar, congenital anomaly, or disparate renal size All children with persistent BP 95th percentile Renal U/S R/O renal scar, congenital anomaly, or disparate renal size

Clinical Evaluation of Confirmed Hypertension Study or Procedure Purpose Target Population Evaluation for identifiable causes History, including sleep history, family history, risk factors, diet, and habits such as smoking and drinking alcohol; physical examination BUN, creatinine, electrolytes, urinalysis, urine culture CBC Renal ultrasound History and physical examination help focus subsequent evaluation R/O renal disease and chronic pyelonephritis R/O anemia, consistent with chronic renal disease R/O renal scar, congenital anomaly, or disparate renal size All children with persistent BP >95th percentile All children with persistent BP >95th percentile All children with persistent BP >95th percentile All children with persistent BP >95th percentile

Clinical Evaluation of Confirmed Hypertension Study or Procedure Purpose Target Population Evaluation for comorbidity Fasting lipid panel, fasting glucose Drug screen Polysomnography To identify hyperlipidemia, identify metabolic abnormalities To identify substances that might cause hypertension To identify sleep disorder in association with hypertension Overweight patients with BP at 90th 94th percentiles; all patients with BP >95th percentile Family history of hypertension or cardiovascular disease Child with chronic renal disease History suggestive of possible contribution by substances or drugs History of loud, frequent snoring

Clinical Evaluation of Confirmed Hypertension Study or Procedure Purpose Target Population Evaluation for target-organ damage Echocardiogram Retinal examination Further evaluation as indicated Identify LVH and other indications of cardiac involvement Identify retinal vascular changes Patients with comorbid risk factors* and BP at the 90th 94th percentiles; all patients with BP >95th percentile Patients with comorbid risk factors and BP at the 90th 94th percentiles; all patients with BP >95th percentile Ambulatory BP monitoring Identify white-coat hypertension, abnormal diurnal BP pattern, BP load Patients in whom white-coat hypertension is suspected, and when other information on BP pattern is needed *Comorbid risk factors also include diabetes mellitus and kidney disease

Clinical Evaluation of Confirmed Hypertension Study or Procedure Purpose Target Population Plasma renin determination Identify low renin, suggesting mineralocorticoid-related disease Young children with stage 1 hypertension and any child or adolescent with stage 2 hypertension Positive family history of severe hypertension Renovascular imaging Identify renovascular disease Young children with stage 1 hypertension and any child or adolescent with stage 2 hypertension Plasma and urine steroid levels Plasma and urine catecholamines Identify steroid-mediated hypertension Identify catecholaminemediated hypertension Young children with stage 1 hypertension and any child or adolescent with stage 2 hypertension Young children with stage 1 hypertension and any child or adolescent with stage 2 hypertension

Other Noninvasive tests for diagnosis of HBP in children Screen for renal vascular diseases: o Magnetic resonance angiography (MRA) o Computed tomographic angiography (CTA) o Duplex Doppler ultrasonography for evaluation of hypertension o In children renal doppler has a low sensitivity/specificity for diagnosis of renal artery stenosis.

Treatment of hypertension in children & adolescents MANAGEMENT OF HTN NON PHARMACOLOGICAL PHARMACOLOGICAL

Classification of Hypertension in Children and Adolescents with Therapy Recommendations Normal Prehypertension Therapeutic Lifestyle Changes Encourage healthy diet, sleep, and physical activity. Recommend weight management counseling if overweight; introduce physical activity and diet management. Stage 1 hypertension Stage 2 hypertension Recommend weight management counseling if overweight; introduce physical activity and diet management. Recommend weight management counseling if overweight; introduce physical activity and diet management.

Indications for Antihypertensive Drug Therapy in Children Symptomatic hypertension Secondary hypertension Hypertensive target-organ damage Diabetes (types 1 and 2) Persistent hypertension despite nonpharmacologic measures

European Society of Hypertension Recommendations for Hypertensive Medications in Pediatric Patients Drug Class Indications Contraindications Bilateral renal artery stenosis Chronic kidney disease Chronic kidney disease Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) Diabetes mellitus Congestive heart failure Renal artery stenosis in solitary kidney Hyperkalemia Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) Diabetes mellitus Congestive heart failure Pregnancy Calcium channel blockers Post-transplantation Congestive heart failure Calcium channel blockers Post-transplantation Beta-blockers Coarctation of the aorta Asthma Beta-blockers Coarctation of the aorta

Medication Drug Class Indications Contraindications Drug Class Indications Bilateral renal artery stenosis Chronic kidney disease Chronic kidney disease Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) Diabetes mellitus Renal artery stenosis in solitary kidney Hyperkalemia Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) Diabetes mellitus Congestive heart failure Congestive heart failure Pregnancy Calcium channel blockers Post-transplantation Congestive heart failure Calcium channel blockers Post-transplantation Beta-blockers Coarctation of the aorta Asthma Beta-blockers Coarctation of the aorta Hyperaldosteronism Hyperaldosteronism Potassium-sparing diuretics Chronic renal failure Chronic renal failure Potassium-sparing diuretics Chronic renal failure Loop diuretics Congestive heart failure Loop diuretics Congestive heart failure

Conclusion o Essential hypertension, for which no identifiable cause is found, can begin in childhood. o Children usually have secondary forms of hypertension due to underlying cardio-renal diseases. o Children who have high blood pressure tend to be hypertensive as adults. o It is mandatory to investigations for secondary causes of HBP o Treatment can be pharmacological or non pharmacological o Hypertensive crisis should be treated in ICUSs

Management algorithm. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents Pediatrics 2004;114:555-576 2004 by American Academy of Pediatrics